Sign In

Mary Mallaney

Director, Early CMC Portfolio and Technical Writing at Bristol Myers Squibb

Professional Background

Mary Mallaney is a highly motivated and self-starting professional with extensive experience in the biopharmaceutical industry. Throughout her career, Mary has consistently demonstrated a strong commitment to effective communication and leadership, underscoring her passion for motivating teams and organizations to achieve their goals. Her dedication to continuous self-improvement contributes to her ability to innovate in her field, particularly in technologies that promote sustainability across various domains, including environmental, population, and political aspects.

Mary's career began at Genentech, where she held several roles over a span of years. She started as an Associate Engineer and advanced through different levels to become an Engineer II and later a Senior Engineer. This progression allowed her to develop a robust skill set in chemical engineering, further enriching her expertise in biomolecular engineering. Her hands-on experience in a leading biopharmaceutical firm positioned her perfectly for exciting opportunities at Juno Therapeutics, Inc.

At Juno Therapeutics, Mary climbed the career ladder rapidly, holding several significant roles. She first served as a Senior Engineer, where she contributed to various projects impacting the company’s strategic direction. Her impressive performance earned her a promotion to Senior Manager, CMC Strategy Lead, which enabled her to manage critical components of the company’s manufacturing and chemistry, manufacturing, and controls strategies. Her ability to lead teams at Juno equipped her with invaluable insights into the complexities of biopharmaceutical development, ultimately leading her to her position as Associate Director, CMC Team Leader. In this role, Mary further exemplified her leadership capabilities, directly influencing the success of projects and the efficacy of teams she led.

Currently, Mary holds the esteemed position of Director at Bristol Myers Squibb, where she continues to apply her deep expertise and commitment to sustainable practices in the pharmaceutical industry. Her role involves overseeing significant projects that align with the company's mission to deliver innovative medicines while ensuring a positive impact on society and the environment. Through her leadership at Bristol Myers Squibb, she remains focused on driving change in her organization and the larger industry landscape.

Education and Achievements

Mary Mallaney earned her Bachelor of Science degree in Chemical and Biomolecular Engineering from the prestigious Johns Hopkins University. Renowned for its rigorous curriculum and innovative research opportunities, this institution has equipped Mary with the foundational knowledge and technical competencies essential for her dynamic career. Her education serves as a testament to her dedication to academic excellence and her commitment to using her skills to positively impact the world through technology and sustainability.

In addition to her formal education, Mary has also participated in various projects and research initiatives during her time at educational institutions, including the Johns Hopkins University and University Hospital Basel. Such experiences have enriched her research capabilities and cultivated her understanding of the practical applications of chemical engineering in real-world settings. Mary’s proactive approach to her education has played a significant role in shaping her successful career in the biopharmaceutical sector.

Achievements

Mary Mallaney’s career thus far has been marked by numerous achievements that highlight her effectiveness as a leader and innovator. At Juno Therapeutics, she played an instrumental role in enhancing the company’s operational efficiency, ultimately contributing to the development of breakthrough therapies in the realm of immunotherapy and oncology. Her strategic oversight and ability to navigate complexities in research, development, and production have garnered her respect among peers and leaders in the industry.

As Director at Bristol Myers Squibb, Mary has continued to advocate for innovative practices that push the boundary of science and health. Her leadership extends beyond mere project management, as she fosters a culture of collaboration and innovation among her teams, encouraging each member to contribute to the larger objectives of the organization.

Mary is not just passionate about her direct work but also about contributing to global sustainable practices within the industry. She engages in initiatives aimed at minimizing the environmental footprint of pharmaceutical production and strives to create processes that enhance overall sustainability in production methodologies. Her efforts reflect her belief in harmonizing corporate growth with social responsibility.

In summary, Mary Mallaney is a passionate professional whose experience in chemical and biomolecular engineering positions her at the forefront of the biopharmaceutical field. She combines her educational background with practical experience to lead impactful projects and advocate for sustainable practices within the industry. With a career marked by continuous growth, innovation, and a deep commitment to effective communication, Mary inspires those around her and actively contributes to a brighter and more sustainable future.

Related Questions

How did Mary Mallaney develop her expertise in chemical and biomolecular engineering?
What innovative strategies has Mary Mallaney implemented at Bristol Myers Squibb? How does Mary Mallaney approach team motivation and communication in her leadership roles?
What role did Mary Mallaney play in the development of therapies at Juno Therapeutics?
How does Mary Mallaney integrate sustainable practices into biopharmaceutical production processes?
Mary Mallaney
Add to my network

Location

Greater Seattle Area